M&A Deal Summary

Bausch Health Acquires NicOx

On November 17, 2014, Bausch Health acquired healthcare services company NicOx from Nicox for 20M USD

Acquisition Highlights
  • This is Bausch Health’s 2nd transaction in the Healthcare Services sector.
  • This is Bausch Health’s 25th largest (disclosed) transaction.
  • This is Bausch Health’s 15th transaction in the United States.
  • This is Bausch Health’s 5th transaction in New Jersey.

M&A Deal Summary
Date 2014-11-17
Target NicOx
Sector Healthcare Services
Buyer(s) Bausch Health
Sellers(s) Nicox
Deal Type Divestiture
Deal Value 20M USD

Target

NicOx

Warren Township, New Jersey, United States
NicOx, Inc. distributes nitric oxide (NO)-donating drug.

Search 193,605 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada

website

Category Company
Sector Life Science
Employees19,900
Revenue 8.1B USD (2022)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 27 of 35
Sector (Healthcare Services) 2 of 2
Type (Divestiture) 7 of 9
State (New Jersey) 5 of 5
Country (United States) 15 of 22
Year (2014) 2 of 2
Size (of disclosed) 25 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-03 PreCision Dermatology

Cumberland, Rhode Island, United States

PreCision Dermatology, Inc. is a specialty pharmaceutical company developing, manufacturing and marketing prescription and consumer dermatology products. Our mission is to develop innovative skincare therapies with proven clinical performance that patients prefer and physicians are confident to prescribe.

Buy $475M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-22 Salix Pharmaceuticals

Raleigh, North Carolina, United States

Salix Pharmaceuticals Ltd. is a developer and marketer of prescription pharmaceutical products and medical devices for the prevention and treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic products, complete any required development and regulatory submission of these products, and market them through Salix's gastroenterology specialty sales and marketing team.

Buy $14.5B

Seller(S) 1

SELLER

Nicox

Valbonne, France

website

Category Company
Founded 1996
Sector Life Science
Employees34
Revenue 5M EUR (2022)
DESCRIPTION

Nicox is an international company focused on the ophthalmic market. With a heritage of innovative R&D, business development and commercial expertise, the Nicox team is building a diversified portfolio of therapies and diagnostic tools that can help people to enhance their sight. Nicox was founded in 1996 and is based in Valbonne, France.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-24 Aciex Therapeutics

Boston, Massachusetts, United States

Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases.

Buy $120M
Mergr

Product

Company

Legal